News Releases

Check presentation

Published by:
Krystle Barbour
Media and Public Relations Manager
University of Minnesota Medical School

“Fourteen years ago I was diagnosed with stage 1 testicular cancer,” said Scott Petinga. “Everyone said it was the best kind you can get — since it had a survivor rate of 99 percent. But I wound up with every side effect you could receive.”

Dr. Jaime Modiano

MINNEAPOLIS, MN - As Jim Valvano was accepting the Arthur Ashe Courage and Humanitarian Award at the inaugural ESPYS on March 4, 1993, he said “Don't Give Up . . . Don’t Ever Give Up!”® His words have inspired a generation, and the V Foundation for Cancer Research was born that night. The organization has since provided over $225 million in cancer research grants nationwide.

Lab image

MINNEAPOLIS/ST. PAUL (1/18/2019) — Ovarian cancer research at the University of Minnesota takes another leap forward as two cancer research projects receive grants from the Department of Defense (DOD) office of the Congressionally Directed Medical Research Programs (CDMRP).

Branden Moriarity, PhD

Funding allows further testing of genome editing technologies

MINNEAPOLIS, MN- January 18, 2019 - University of Minnesota researchers embark on work which could lead to a cure for some genetic diseases, such as cancer. Thanks to a U24 grant, part of the NIH Common Fund’s Somatic Cell Gene Editing (SCGE) consortium, Branden Moriarity, PhD, Assistant Professor in the Department of Pediatrics at the University of Minnesota Medical School and Masonic Cancer Center member, will begin to test genome editing technologies.

The Hormel Institute logo

The Hormel Institute's Dr. Rebecca Morris publishes discovery in leading journal Nature Communications


Robert Turesky, PhD, Professor of Medicinal Chemistry in the College of Pharmacy at the University of Minnesota, has been appointed as the Masonic Chair in Cancer Causation.

mayo clinic mankato

A new study looking at the impact of ginger extract on the gut bacteria in people who have had a colonoscopy and had polyps removed is open in Mankato, Minnesota. This cancer prevention study, brought to Mayo Clinic Health System in Mankato through the Minnesota Cancer Clinical Trials Network (MNCCTN), is now open to eligible participants.